BPG is committed to discovery and dissemination of knowledge
Featured Articles
1/11/2023 2:15:18 AM | Browse: 406 | Download: 2251
Publication Name World Journal of Clinical Oncology
Manuscript ID 80526
Country China
Received
2022-10-05 22:05
Peer-Review Started
2022-10-05 22:07
First Decision by Editorial Office Director
2022-10-24 03:12
Return for Revision
2022-10-24 03:12
Revised
2022-11-02 09:06
Publication Fee Transferred
Second Decision by Editor
2022-12-14 04:07
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2022-12-14 18:08
Articles in Press
2022-12-14 18:08
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-01-05 09:55
Publish the Manuscript Online
2023-01-11 01:30
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Basic Study
Article Title 5-mRNA-based prognostic signature of survival in lung adenocarcinoma
Manuscript Source Invited Manuscript
All Author List Qian-Lin Xia, Xiao-Meng He, Yan Ma, Qiu-Yue Li, Yu-Zhen Du and Jin Wang
Funding Agency and Grant Number
Funding Agency Grant Number
the Science and Technology Development Fund of the Pudong New Area PKJ2021-Y53
National Natural Science Foundation of China 81974315
Corresponding Author Jin Wang, PhD, Professor, Scientific Research Center, Shanghai Public Health Clinical Center, Fudan University, No. 2901 Caolong Road, Jinshan District, Shanghai 201518, China. wjincityu@yahoo.com
Key Words Lung adenocarcinoma; Differentially expressed genes; Prognostic signature; Risk score; Nomogram
Core Tip Five differentially expressed genes (DEGs) (TCN1, CENPF, MAOB, CRTAC1, and PLEK2) selected by multiple Cox regression analysis in the prognostic risk models could be considered as independent prognostic factors for lung adenocarcinoma.
Publish Date 2023-01-11 01:30
Citation Xia QL, He XM, Ma Y, Li QY, Du YZ, Wang J. 5-mRNA-based prognostic signature of survival in lung adenocarcinoma. World J Clin Oncol 2023; 14(1): 27-39
URL https://www.wjgnet.com/2218-4333/full/v14/i1/27.htm
DOI https://dx.doi.org/10.5306/wjco.v14.i1.27
Full Article (PDF) WJCO-14-27.pdf
Full Article (Word) WJCO-14-27.docx